The PennZone

  • Home
  • Business
  • Health
  • Braces
  • Dentist
  • Entertainment
  • Non-profit
  • Real Estate
  • Music

Beneficience.com Legacy PR Announces Dr. Burd Renowned Diabetes Scientist, Biochemist-entrepreneur and Dexcom Founder, client
The PennZone/10216335

Trending...
  • Alcoa Announces Closure of Intalco Smelter and Prepares Site for Redevelopment
  • Pennsylvania: Gov. Shapiro Highlights Plans to Rebuild Workforce, Recruit More Teachers into PA Classrooms During Visit to Philadelphia High School
  • Empowering SMEs: Innervation's Supply Chain Finance Solutions for Diverse Business Growth
Beneficience Com Announces Dr John Burd, Renowned Dr John Burd Lysulin© Dr Burd Wonder Spray Skin Rescue 8oz Skin Rescue Lysulin© Products Beneficience.com Legacy PR
Dr. Burd is a renowned diabetes scientist and biochemist and Founder of Dexcom, the worldwide leader in Continuous Glucose Monitoring (CGM) systems. Get to know him and what good he is doing in the world, and for whom his life work benefits.

SAN DIEGO - PennZone -- About John Burd, PhD:

Dr. Burd is Founder & CEO of Lysulin, Inc and Wonder Spray, llc.  In 2017 Dr. Burd founded Lysulin, Inc, developing scientifically proven nutraceutical products to improve the health of people with diabetes.   The first patented product, Lysulin®, was launched in January 2018 and is showing remarkable results in clinical studies in lowering HbA1c and glycated proteins, the cause of disease complications.  In 2019 Dr. Burd founded Wonder Spray, llc to provide relief for a variety of ailments and skincare problems using a natural and safe chemical that is used by white blood cells to kill all pathogens.

Dr. Burd was previously President & CEO of DexCom, where he directed the company's work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes.  In April 2005, DexCom completed a successful IPO, valuing the company at over $500 million.  In 2020 DexCom had a market cap of over $40 billion.  From 1999 to 2004 Dr. Burd was a General Partner of Windamere Venture Partners.

Before founding DexCom, Dr. Burd was the Founder, President, CEO and Chairman of LXN Corporation, which developed and marketed the Duetâ Diabetes Control System to healthcare professionals and the In ChargeÔ Diabetes Control System to the diabetes self-testing market.  LXN was sold to Johnson and Johnson in 2000.

More on The PennZone
  • Announcing the Dr. Monti Show on Integrative Health and the Intersection of Science, Health, and Personal Well-Being, Premiering March 24, 2023, at 7:30pm
  • Dental Implants in Center Valley Helping Patients Achieve Fuller Smiles
  • Wohler releases out-of-band configuration tools for Riedel 2110 SFP's
  • Benjamin Ross Group, LLC Sells Manufacturing Company, Frederick County, VA
  • Levinger Regens Announces New Initiative to Improve Hydrogen Carbon Intensity

Previously, Dr. Burd held executive positions at QUIDEL Corporation, where he directed the development of enzyme immunoassay products for the clinical lab, physician's office and OTC markets. Prior to joining QUIDEL, Dr. Burd was Executive Vice President and COO for MAST Immunosystems, Inc. where he was responsible for the company's operations, including research and development, marketing, sales and finance.  MAST Immunosystems was purchased by Hitachi Chemical in 1997.  Previously, Dr. Burd was involved in other medical product research and development at Miles Laboratories, Inc. (now Bayer Corporation).

Dr. Burd has authored and co-authored over 45 articles and his work in the medical and biotechnology field has led to the filing and ownership of forty patents and the development of many innovative medical products.  He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin.  In 2010 Dr. Burd was inducted into the American Association of Clinical Chemistry Hall of Fame and received the Ullman Prize for innovation in clinical chemistry.

Disclaimer: Dr. Burd's published product statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

JOHN F. BURD, Ph.D.

Founder & CEO Lysulin, Inc and Wonder Spray, llc.
4930 Bradshaw Court, San Diego, CA  92130

More on The PennZone
  • Eve Wellness, a SF Breast Ultrasound Screening Clinic supports the recent FDA updates to the guidelines to inform women about breast density
  • Strategic Solution Partners Expands Its Hospitality Consulting Team to make Executive-Level Advice Available to Hotel Operators
  • Expert tip: Private Jet Engine Maintenance Program - Pros and Cons for Preowned Jet Buyers
  • Gaming and entertainment company Spinrack Corporation, appoints Jesse Norton as Chief Marketing Officer
  • Pizzawiki.com: The Ultimate Pizza Resource for Pizza Lovers Everywhere!

Phone: 619-992-2873

Website: Promotes Healthy Insulin Function and helps maintain healthy A1c (lysulin.com)

Learn more about Dr. Burd's products below...

Insulin resistance: https://www.youtube.com/watch?v=rdiHqff3EY8



Lysulin video:  https://www.youtube.com/watch?v=PK3CkMty6RE



Running A1c test: https://tinyurl.com/y379jbla

Wonder Spray:
https://www.youtube.com/channel/UCYFv1jgn3LmADcZklzLbMHA/videos

Follow Burd's PR News at http://Beneficience.com

MEDIA REQUESTS + MEDIA BOOKING: Dr. Burd is available for relevant events, speaking engagements, radio, podcast, television and media opportunities, news interviews, et als. Burd's media contact information is available now by request online at Beneficience.com Legacy PR at https://beneficience.com/?s=Dr.+John+Burd

Contact
Dr. Tracey Bond, MPRL
Certified Publicist of Record
for John Burd, PhD
***@beneficience.com


Source: Beneficience.com Legacy PR
Filed Under: Business, Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • HGR Alcohol Detox Centers in San Diego Accepts Most Health Insurances
  • INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fidelity National Information Services, Inc. (FIS) Investors
  • ShopCHARLI.com Launches Online Store With a Hot New Spring Collection that Doesn't Miss
  • ICYMI: Governor Shapiro Touts His Plans to Rebuild Pennsylvania's Workforce, Recruit More Teachers, Cops, & Nurses
  • Bounce House Rentals Near Me Provider for Pittsburgh PA And Surrounding Areas
  • Pennsylvania: Governor Josh Shapiro Highlights Commonsense Proposal to Recruit More Nurses, Invest in Healthier Communities
  • Congressman Mark Alford endorsed by Veterans for Trump on his 2024 re-election
  • February 2023 Financial Market Review
  • Bicycle Sunshade Expands Product Line with Two New Colors
  • The Past Reflects A Future - Daniel Imperato 2024 Is Back Again. Which Party?
  • Performance Hydration Leader Ready® Joins Global Tennis Market
  • INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Marathon Digital Holdings, Inc. (MARA) on Behalf of Investors
  • Fridge Art Fair New York City May 2023
  • Empowering SMEs: Innervation's Supply Chain Finance Solutions for Diverse Business Growth
  • AdvisorVault Partners With Compliant Workspace to Help FINRA Firms Achieve 17a-4 Compliance on Microsoft 365
  • Alcoa Announces Closure of Intalco Smelter and Prepares Site for Redevelopment
  • Pennsylvania: Governor Josh Shapiro Highlights Commonsense Proposal to Recruit More Police Officers and Invest in Public Safety at Lackawanna College Police Academy
  • Pennsylvania: Gov. Shapiro Highlights Plans to Rebuild Workforce, Recruit More Teachers into PA Classrooms During Visit to Philadelphia High School
  • RE/MAX Classic Realtors Announces Top Honors for Their High Achieving Real Estate Teams
  • Free Training From The Tax Lien Lady – Tax Lien Investing 3-Day Challenge!

Popular on PennZone

  • All Dry Services of Rostraver Lends a Wing to Fight Hunger in Westmoreland County
  • Social Media vs. Mainstream Media : Quality and Speed of News Story Information
  • Supercute World™ Partners with AI-Fashion Powerhouse Merchadise™ on First Apparel Collection
  • Buy or Sell with Beck Properties Group and Get a Free Moving Trailer
  • Award-winning Children's Author Honored at Black Superhero Black History Month Celebration
  • Accendo's Talent Intelligence Platform Secures Pre-Series A Funding from The Hive SEA and OSK Ventures
  • Adair Family Clinic and Medspa Announces New Skincare Experience
  • Detego Global Teams Up with FCI to Deliver Free Access to Cutting-Edge Digital Forensics Tools
  • Sip Social Co. Mobile Bar Rental Business Expands Into Additional U.S. Markets
  • Researchers develop first self-healing, electrically conducive, soft material

Similar on PennZone

  • Eddie Turner is Recognized as the #9 Motivational Speaker in the World By Global Gurus!
  • Celebrity chef, podcast host Maria Liberati wins COMCAST Media Rise Award
  • Announcing the Dr. Monti Show on Integrative Health and the Intersection of Science, Health, and Personal Well-Being, Premiering March 24, 2023, at 7:30pm
  • Dental Implants in Center Valley Helping Patients Achieve Fuller Smiles
  • Wohler releases out-of-band configuration tools for Riedel 2110 SFP's
  • Levinger Regens Announces New Initiative to Improve Hydrogen Carbon Intensity
  • Eve Wellness, a SF Breast Ultrasound Screening Clinic supports the recent FDA updates to the guidelines to inform women about breast density
  • Strategic Solution Partners Expands Its Hospitality Consulting Team to make Executive-Level Advice Available to Hotel Operators
  • Expert tip: Private Jet Engine Maintenance Program - Pros and Cons for Preowned Jet Buyers
  • Gaming and entertainment company Spinrack Corporation, appoints Jesse Norton as Chief Marketing Officer
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us